Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study.

ABSTRACT:

SUBMITTER: Allaf ME 

PROVIDER: S-EPMC11323681 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature